DLA Piper, a multinational law firm, announced the induction of Lily Wound, a seasoned attorney, as a partner in its corporate practice in the New York office, as reported on Bloomberg Law.
Wound’s areas of expertise lie in representing pharmaceutical, biotechnology, and other life sciences companies in commercial, corporate, and licensing transactions a statement by DLA Piper read. Her track record boasts of handling transactions throughout the life cycle of products.
With legal professionals needing to constantly navigate the complexities of various industry standards, Wound’s experience in a diverse array of areas will be pivotal to DLA Piper’s work. Furthermore, her joining occurs at a time when corporate practices, especially those dealing with the life sciences sector, face challenges due to the rapid advancements in technology and stringent regulatory environment.
DLA Piper’s expansion hints at the continuing evolution and growing complexity of corporate legal landscapes. The addition of Wound to the firm’s team indicates their commitment to strengthen their service across relevant sectors and deepen the firm’s capabilities in responding to the dynamic needs of its clients.
For more information about Lily Wound’s appointment as a new partner at DLA Piper’s corporate practice, click here.